AUTOSYNVAX

Serial Number 86826504
606

Registration Progress

Application Filed
Nov 19, 2015
Under Examination
Nov 15, 2016
Approved for Publication
May 17, 2016
Published for Opposition
May 17, 2016
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: AUTOSYNVAX
Previous Owner: AGENUS INC.
Classes: 044

Trademark Image

AUTOSYNVAX

Basic Information

Serial Number
86826504
Filing Date
November 19, 2015
Published for Opposition
May 17, 2016
Abandonment Date
December 16, 2019
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Dec 16, 2019
Classes
044

Rights Holder

AGENUS INC.

03
Address
3 Forbes Road
LEXINGTON, MA 024217305

Ownership History

AGENUS INC.

Original Applicant
03
LEXINGTON, MA

AGENUS INC.

Owner at Publication
03
LEXINGTON, MA

Legal Representation

Attorney
Christina M. Licursi

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

44 events
Date Code Type Description Documents
Dec 16, 2019 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Dec 16, 2019 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
May 17, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 16, 2019 EX5G S SOU EXTENSION 5 GRANTED Loading...
May 13, 2019 EXT5 S SOU EXTENSION 5 FILED Loading...
May 16, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
May 13, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 17, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 15, 2018 EX4G S SOU EXTENSION 4 GRANTED Loading...
Nov 15, 2018 EXT4 S SOU EXTENSION 4 FILED Loading...
Nov 15, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 15, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 11, 2018 EX3G S SOU EXTENSION 3 GRANTED Loading...
May 11, 2018 EXT3 S SOU EXTENSION 3 FILED Loading...
May 11, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 17, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 15, 2017 EX2G S SOU EXTENSION 2 GRANTED Loading...
Nov 15, 2017 EXT2 S SOU EXTENSION 2 FILED Loading...
Nov 15, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 11, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 9, 2017 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 9, 2017 EXT1 S SOU EXTENSION 1 FILED Loading...
May 9, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 15, 2016 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 30, 2016 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Loading...
Aug 29, 2016 CHPB I CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED Loading...
Aug 25, 2016 APET A ASSIGNED TO PETITION STAFF Loading...
Aug 3, 2016 EPPA I TEAS POST PUBLICATION AMENDMENT RECEIVED Loading...
Jun 15, 2016 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
May 16, 2016 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
May 16, 2016 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
May 17, 2016 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 17, 2016 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 27, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 1, 2016 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 17, 2016 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Mar 17, 2016 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Mar 17, 2016 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Mar 17, 2016 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 11, 2016 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN Loading...
Mar 11, 2016 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 11, 2016 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 25, 2015 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 23, 2015 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 044
Medical, pharmaceutical and health care services, namely, providing information and advice to patients and health care professionals regarding the use of pharmaceutical agents and biopharmaceutical agents, including vaccines, immunotherapeutics, and other therapeutic agents, for the prevention or treatment of human diseases
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
044